References
- Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach, 7th ed. Edinburgh: Elsevier Saunders, 2011.
- Vardiman JW. Chronic myelogenous leukemia, BCR‐ABL1+. Am J Clin Pathol 2009; 132: 250–260.
- Khoury HJ, Williams LA, Atallah E et al. Chronic myeloid leukaemia: what every practitioner needs to know in 2017. Am Soc Clin Oncol Educ Book 2017; 37: 468–479.
- Giammarco S, Chiusolo P, Piccirillo N et al. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol 2017; 10: 147–154.
- Pham HP, Schwartz J. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis. Transfusion 2015; 55: 2306–2311.
- Van der wijk A‐E, Hughes JM, Klaassen I et al. Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy? J Leukoc Biol 2017; 102: 993–1001.
- Newcott EK, Ellabban AA, Tavassoli S, et al. Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy. Case Rep Ophthalmol Med 2015; 2015: 713868.
- Horgan SE, Fraser SG, Ferrante PF et al. Cystoid macular oedema in chronic myeloid leukaemia: treatment with acetazolamide and response to bone marrow transplantation. Eye 1996; 10: 394–396.
- Georgalas I, Pavesio C, Ezra E. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1585–1586.
- Masood I, Negi A, Dua HS. Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery. J Cataract Refract Surg 2017; 31: 2427–2428.